Skip to main content
AroCell AB logo

AroCell AB — Investor Relations & Filings

Ticker · AROC ISIN · SE0003883990 LEI · 549300RF3VQBLGOJ7J46 ST Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing ST AROC

About AroCell AB

https://arocell.com/

IDL Diagnostics AB, formerly AroCell AB, is a diagnostics company that develops and markets in vitro diagnostic (IVD) tests for oncology and bacteriology. The company's portfolio aims to provide high-value clinical information for disease detection, prognosis, and monitoring. Key products in oncology include the TK 210 ELISA, a cell proliferation biomarker for assessing therapy response in various cancers, and the UBC® Rapid, a point-of-care test for bladder cancer. In bacteriology, the company provides the TUBEX® TF rapid test for the detection of acute typhoid fever. IDL Diagnostics also licenses tumor markers to strategic partners.

Recent filings

No filings indexed yet

We are still gathering filings for AroCell AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.